Legal Opinion
In re Genetic Technologies Ltd. (´179) Patent Litigation
United States Judicial Panel on Multidistrict Litigation
Decided August 3, 2012No. MDL No. 2376PublishedCited by 3 opinions
1Opinion of the Court
ORDER DENYING TRANSFER
JOHN G. HEYBURN II, Chairman.
Before the Panel: * Pursuant to 28 U.S.C. § 1407, patentholder Genetic Teehnologies Limited (GT) seeks centralization in the District of Colorado or, alternatively, the Northern District of California of six actions involving the alleged infringement of a patent concerning methods of genetic testing. This litigation currently consists of six actions1 listed on Schedule A and pending in four districts.
All responding defendants oppose centralization. Defendants Bristol-Myers Squibb Co., Pfizer, Inc., and Merial LLC alternatively suggest…
2Cases cited2 opinions
- In Re Eli Lilly & Co.(cephalexin Monohydrate)United States Judicial Panel on Multidistrict Litigation · 1978
- In re Arrivalstar S.A. Fleet Management Systems Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2011
3Cited by3 opinions
- In re Brandywine Communications Technologies, LLC, Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2013
- In re Blue Spike, LLCUnited States Judicial Panel on Multidistrict Litigation · 2017
- In re High Quality Printing Inventions, LLCUnited States Judicial Panel on Multidistrict Litigation · 2016